focus -WSS

focus

author：comprehensive 2025-08-17 00:02:33 - browse：5

Alex Hogan/STAT

The J.P. Morgan Healthcare Conference is upon us, bringing its frenetic meetings, crowded hallways, and hotel rooms so expensive that even the pharmaceutical industry complains about what a free market does to the prices of scarce goods.

This year’s iteration, starting Monday in San Francisco, finds the biotech industry, in particular, in a curious spot. After a volatile 2023 that saw biotech stocks hit five-year lows in the fall, the sector had a bull run in the final weeks of the year, spurred by some high-dollar merger agreements and a prevailing sense that the macroeconomic winds were finally shifting in biotech’s direction.

Meanwhile, companies selling digital health services like telemedicine, health plans for virtual care, and AI tools for payers face a crucial year as they scramble to make good on profitability projections. Those companies, along with the country’s most powerful health systems, are seriously exploring AI, even ChatGPT, to help them meet financial milestones.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Drug repurposing or repositioning? The language matters
Next article： New CMS data security rules will hurt Medicare, Medicaid research

focus

leisure time

WSS

How to address the problem of discarded donor organs

FDA does about

ALS groups 'won't be played again' by the FDA, drug sponsors

An inside look at PIPEs, biotech's buzzy new financing tool

Abortion pill mifepristone to soon be dispensed at CVS, Walgreens

WATCH: Why do our ears pop?

focus

focus

hotspot

How one medical school became remarkably diverse

MD Anderson's Padmanee Sharma responds to research credit suit

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Obesity now affects over 1 billion people worldwide, study finds

Continuity nursing helped my family in our darkest PICU moments

Scientists unlock the key to scar

Walensky prepares to leave CDC — and Congress — behind

As AI regulations shape up, health tech startups beg for clarity

New air purifier tech could be key to improving indoor air quality

Clinical trials giant ICON acquires HumanFirst

focus

Hospitals are piloting generative AI tools as regulators play catch

Abortion pill mifepristone to soon be dispensed at CVS, Walgreens

Measles policy set amid Florida outbreak alarms vaccine proponents

How to fix the rural physician shortage in the U.S.

Medicare Advantage enrollment hits roughly 33.4 million

Congress gives doctors Medicare pay bump

explore

focus

leisure time

hotspot